Hacker News new | past | comments | ask | show | jobs | submit login

I'm not judging the systems. I, personaly, much rather live under the french nhs than the US one.

But i just wanted to provide some perspective to that generaly over optimistic OP post. The fact that cancer drugs are created in the US is not a coincidence. It's an ecosystem where there is a lot of money to be made, and as we know it in IT, money drives innovation.




ICI discovered tamoxifen before AstraZeneca bought them. They're British. Femara (letrozole) and Afinitor (everolimus) are Novartis (Switzerland). Campostar was discovered by Pharmacia, a Swedish company that's now part of Pfizer.

The U.S. by no means has a monopoly on "cancer drugs".


It would be interesting to see where the labs for those companies are, and what's their primary market.

But thanks, i didn't know that. Maybe the british and swiss R&D isn't in such a bad state as France.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: